Industries We Serve with Our Market Access, Quality Compliance & Regulatory Affairs Consulting Services

Cisema provides trusted regulatory affairs consulting services to help companies succeed across the Asia Pacific region. With deep expertise in China and the Hong Kong SAR, and expanding support across Southeast Asia, South Korea and Taiwan, we work with clients in diverse regulatory environments. Backed by decades of experience in regulatory affairs consulting, our team of regulatory experts delivers comprehensive regulatory services, providing end-to-end support for compliance and approvals. We have a proven track record of achieving successful regulatory outcomes for medical devices, IVDs, pharmaceuticals, quasi-drugs, cosmetics, health products, consumer goods, and industrial products. Our expert guidance ensures smooth market entry, regulatory compliance, and long-term success in one of the world’s most dynamic regions.

Two men in business suits sitting at a table engaged in a meeting with a third person.
Regulatory submissions

Industries We Serve

We support companies in a wide range of regulated industries, with a focus on streamlining compliance and approvals for our clients. We help them meet the evolving regulatory landscape and compliance requirements, accelerate approvals, and maintain product quality throughout the lifecycle. For each industry, we develop a tailored regulatory strategy and identify the optimal regulatory pathway to ensure efficient progression through approval stages and reduce risks.

Medical Devices

We assist manufacturers with product registration, clinical trials, post-market surveillance, quality control, and the implementation of quality management systems. As well as inspection and sourcing services, in China, Hong Kong and Taiwan and across Southeast Asia.

Learn more

In Vitro Diagnostics (IVDs)

Our team helps IVD companies navigate rigorous clinical validation, registration, and post-market requirements, ensuring compliance with the latest regulatory and clinical guidelines. We also deliver quality control, inspection, and sourcing services across China, Hong Kong, Taiwan and Southeast Asia.

Learn more

Pharmaceuticals

From early development through to commercialization, we support drug manufacturers throughout the entire drug development process, providing strategic guidance, submission support, and GMP alignment for success across Asia Pacific.Our team has extensive expertise in the preparation and submission of drug applications, including ANDAs and NDAs, ensuring regulatory compliance and smooth interactions with agencies.

Learn more

Biotech

We provide regulatory guidance for biotech innovators across Asia Pacific, supporting clinical trial design, biosafety clearance, import licensing, and alignment with regulators' expectations.

Learn more

Quasi-Drug Products

We support foreign manufacturers throughout the entire Korean quasi-drug registration process, from initial feasibility assessment and classification through MFDS submission, Korean labeling, import coordination, and ongoing lifecycle compliance.

Learn more

Cosmetics & Ingredients

We support cosmetic and ingredient manufacturers throughout the full product lifecycle in China and Taiwan from pre-registration or notification to post-market. We are your “Responsible Person” and ensure quality compliance with Chinese and Taiwanese regulations, assisting in preparation for NMPA and TFDA audits as required.

Learn more

Health Foods & Supplements

We handle regulatory strategies, raw material approvals, testing, and registrations for dietary supplements and health foods. Our team ensures quality compliance and smooth market entry.

Learn more

Veterinary Drugs & Pet Food

We support MARA interactions, registration, licensing, and testing for pet foods and veterinary medicinal products entering the Chinese market.

Learn more

Industrial Goods & Consumer Products

We help you get your products on the market faster, from electronics and toys to machinery, telecom, and automotive parts. Our team manages CCC, HAF 604, CML, CEL, RoHS, NAL, SRRC, and more. From testing and documentation to renewals and authority approvals, we streamline every step to ensure full compliance with China’s regulations.

Learn more

Why Work with Cisema?

One Partner, Full Lifecycle Support

From pre-market strategy to post-market compliance, we provide support to internal regulatory teams and ensure seamless lifecycle management.

Regional Reach, Global Presence

Based in Asia and Europe with a global team delivering global reach.

Cross-Industry Expertise

Pharma, biotech, medical devices, cosmetics, supplements, veterinary, industrial and consumer goods.

Proven Results

Over 20 years of regulatory submissions, regulatory expertise, and approvals to drive business success.

Why Work with Cisema

Read the Latest Regulatory News

View More

China GACC Revises Filing Rules for Imported Food Importers & Exporters

GACC has simplified filing for imported-food importers and exporters while strengthening port verification, change reporting and ongoing supervision.

November 18, 2026
China GACC Revises Filing Rules for Imported Food Importers & Exporters

Beijing MPA Clarifies Electronic Customs Clearance Pilot for Imported Drugs

Beijing's pilot allows companies to download and print approved import clearance documents digitally, reducing paperwork while maintaining existing regulatory requirements.

November 18, 2026
Beijing MPA Clarifies Electronic Customs Clearance Pilot for Imported Drugs

China Issues GMP Inspection Guidelines for Sterile, Implant, IVD, Denture and Standalone Software Devices

China has introduced GMP inspection guidelines for sterile, implantable, IVD, custom-made denture and standalone software medical devices.

November 16, 2026
China Issues GMP Inspection Guidelines for Sterile, Implant, IVD, Denture and Standalone Software Devices
Two Chinese laboratory professionals check a benchtop blood analyzer as one loads a rack of capped sample tubes.

India Clarifies How Medical Device Software, and AI-Enabled Tools Are Regulated

India’s CDSCO releases final medical device software guidance under MDR 2017, outlining licensing routes, software risk classes, and cybersecurity standards.

November 16, 2026
India Clarifies How Medical Device Software, and AI-Enabled Tools Are Regulated
Two Indian clinicians review a chest X-ray on a tablet, where diagnostic software has flagged an area in one lung.

Singapore Updates GN-15 Medical Device Registration Guidance

Singapore’s HSA has revised GN-15 medical device registration guidance, updating submission templates, SaMD requirements and post-market expectations.

November 12, 2026
Singapore Updates GN-15 Medical Device Registration Guidance

China MARA Releases 7th Edition Veterinary Pharmacopoeia Volume III

Find out which imported veterinary biological products need updated testing, revised registration standards, or regulatory approval before May 2027.

November 3, 2026
China MARA Releases 7th Edition Veterinary Pharmacopoeia Volume III
Previous
Previous

Get in Touch with Our Regulatory Affairs Experts

And discover how we can support you across your various projects in Asia Pacific.

Talk to an Expert